Close Menu

NHGRI

The agency has asked for community input on the document, which is part of its efforts to focus future genomics research initiatives.

The initiative is aiming to solve some of the existing problems in genomics research and build a resource that takes a step beyond gnomAD.

The program will aim to develop and evaluate genomics and informatics tools to improve the diagnosis, treatment, and prevention of disease.

The president's latest budget request marks the fourth time he has sought to reduce funding to the National Institutes of Health.

The National Human Genome Research Institute and the National Cancer Institute also intend to fund the dissemination of genomic resources to the research community.

The NHGRI said it expects to fund between three and five research centers, as well as one coordinating center, over a five year period.

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.

Researchers identified a new type 2 diabetes-associated site involving the ZRANB3 gene, which may have a role in regulating pancreatic beta cells.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.